| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |